Ann: GBM Agile Update, page-28

Management should have asked for the shares to be suspended pending clarification of the announcement. An ambiguous announcement like that is way below what should be expected from JG. We have many posters here interpreting an announcement which James should be doing. Further, what does this announcement mean (assuming it is bad news) for the new SAB and also for the new CSO who was appointed just months ago to further the commercialisation of Paxalisib?

Very poor effort on the part of Management.